ReviewFrontiers in pharmacology2021

Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease.

Guozhi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.